ProfileGDS4718 / 241398_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 39% 39% 40% 50% 37% 36% 41% 51% 39% 47% 41% 35% 36% 39% 46% 39% 38% 36% 35% 33% 55% 42% 36% 43% 39% 37% 38% 39% 40% 34% 36% 32% 43% 51% 33% 39% 34% 41% 40% 42% 45% 39% 35% 41% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9359739
GSM549102patient 115, normal, homogenized [OPG study]4.9504139
GSM549104patient 119, normal, homogenized [OPG study]4.975940
GSM549108patient 138, normal, homogenized [OPG study]5.5539150
GSM549119patient 077, normal, homogenized [OPG study]4.8422937
GSM549133patient 032, cancer, homogenized [OPG study]4.7706436
GSM549139patient 042, cancer, homogenized [OPG study]5.0345741
GSM549099patient 107, normal, homogenized [OPG study]5.5973751
GSM549109patient 139, normal, homogenized [OPG study]4.9640839
GSM549110patient 046, normal, homogenized [OPG study]5.3735947
GSM549114patient 063, normal, homogenized [OPG study]5.0184841
GSM549122patient 082, normal, homogenized [OPG study]4.7783135
GSM549134patient 033, cancer, homogenized [OPG study]4.8107536
GSM549136patient 036, cancer, homogenized [OPG study]4.8886239
GSM549140patient 044, cancer, homogenized [OPG study]5.2414146
GSM549111patient 047, normal, homogenized [OPG study]4.9227839
GSM549113patient 057, normal, homogenized [OPG study]4.8581638
GSM549132patient 031, cancer, homogenized [OPG study]4.7798936
GSM549137patient 038, cancer, homogenized [OPG study]4.7366235
GSM549142patient 047, cancer, homogenized [OPG study]4.8053733
GSM549100patient 110, normal, homogenized [OPG study]5.8181655
GSM549107patient 135, normal, homogenized [OPG study]5.0791442
GSM549115patient 068, normal, homogenized [OPG study]4.7618836
GSM549116patient 072, normal, homogenized [OPG study]5.1120343
GSM549120patient 078, normal, homogenized [OPG study]4.9291339
GSM549131patient 030, cancer, homogenized [OPG study]4.7819737
GSM549118patient 074, normal, homogenized [OPG study]4.9117338
GSM549129patient 027, cancer, homogenized [OPG study]4.9699239
GSM549123patient 088, normal, homogenized [OPG study]4.9551640
GSM549124patient 006, cancer, homogenized [OPG study]4.7567634
GSM549126patient 015, cancer, homogenized [OPG study]4.7923536
GSM549128patient 025, cancer, homogenized [OPG study]4.594732
GSM549103patient 117, normal, homogenized [OPG study]5.2084243
GSM549117patient 073, normal, homogenized [OPG study]5.5399751
GSM549138patient 041, cancer, homogenized [OPG study]4.6354133
GSM549141patient 045, cancer, homogenized [OPG study]4.8963239
GSM549130patient 028, cancer, homogenized [OPG study]4.7257734
GSM549101patient 111, normal, homogenized [OPG study]5.0762441
GSM549105patient 128, normal, homogenized [OPG study]5.0042840
GSM549106patient 134, normal, homogenized [OPG study]5.0485342
GSM549112patient 048, normal, homogenized [OPG study]5.245545
GSM549125patient 011, cancer, homogenized [OPG study]4.9456739
GSM549127patient 024, cancer, homogenized [OPG study]4.7710135
GSM549135patient 035, cancer, homogenized [OPG study]5.0102741